Stock & Company Details
Biofrontera Inc $BFRI
Price:
N/A
N/A
15M
$10M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.97
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
BFRI technical indicators
Latest Biofrontera Inc (BFRI) indicator readings as of 2026-11-19.
BFRI's 14-day RSI is 29.2, in oversold territory. ADX reads 26.1, indicating a trending market. MACD (12, 26, 9) is -0.09, below the zero line.
Overview
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.
Finance Bot
Ask your questions
Start by typing a question below.